Budget Impact Analysis of Mepolizumab for Eligible Patients in the Setting of a Severe Asthma Clinic Within Dubai Health Authority (DHA)

PURPOSE: To estimate 5-years budgetary impact of introducing mepolizumab to eligible patients with uncontrolled severe eosinophilic asthma treated at a tertiary care hospital within Dubai Health Authority (DHA). PATIENTS AND METHODS: A budget impact analysis (BIA) model was adapted to the setting of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahboub, Bassam, Mohy, Ahmed, El-Amir, Islam, Lukić, Tamara, Gouhar, Raef, Noibi, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056102/
https://www.ncbi.nlm.nih.gov/pubmed/35502155
http://dx.doi.org/10.2147/CEOR.S343249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056102/
https://www.ncbi.nlm.nih.gov/pubmed/35502155
http://dx.doi.org/10.2147/CEOR.S343249

Ejemplares similares